Food News and Research

RSS

WHO issues best practices for naming new human infectious diseases

The World Health Organization (WHO) today called on scientists, national authorities and the media to follow best practices in naming new human infectious diseases to minimize unnecessary negative effects on nations, economies and people...

8 May 2015

Using mobile app to track intake of vitamin D and calcium

Vitamin D is essential for the maintenance of bone health and may be implicated in other chronic diseases, as well as immunity, but adults in Canada are consistently deficient in dietary vitamin D, by nearly 400 international units per day (IU/d) on average.

8 May 2015

Bamboo could increase spread of hantavirus, warns WSU ecologist

Washington State University researchers say the popularity of bamboo landscaping could increase the spread of hantavirus, with the plant's prolific seed production creating a population boom among seed-eating deer mice that carry the disease.

8 May 2015

UCI receives FDA consent to study stem cell-based treatment for retinitis pigmentosa in clinical trial

A first-of-its-kind stem cell-based treatment for retinitis pigmentosa developed by UC Irvine's Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent from the U.S. Food & Drug Administration for use in a clinical trial.

8 May 2015

Cancer drugs get quick approvals despite little effect on patients, says York U researcher

Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. Joel Lexchin in the School of Health Policy and Management.

8 May 2015

Enlivant's Jerry Carson wins 2015 ALFA Hero Award

Enlivant, a national provider of senior care services, is proud to announce that employee Jerry Carson was honored by the Assisted Living Federation of America with a 2015 Hero Award, a recognition that celebrates outstanding senior living staff members across the nation.

7 May 2015

Unique real-time drug monitoring system

Titan Enterprises assisted CRISI in the early days of development of the unique flow sensor used in the BD Intelliport™, a medication management system for manual intravenous (IV) bolus injections...

From Titan Enterprises Ltd 7 May 2015

Elsevier launches new NFS Journal

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of NFS Journal, a new open access journal.

7 May 2015

Egalet announces business highlights, financial results for first quarter 2015

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today reported business highlights and financial results for the three months ended March 31, 2015.

7 May 2015

MSI completes patient recruitment for STRADA Phase 2 trial for treatment of major depressive disorder

MSI Methylation Sciences, Inc., a pharmaceutical company developing a once-daily oral, small molecule therapy for adjunctive treatment of major depressive disorder (MDD), announced the completion of patient recruitment for its HORIZON Phase 2 Study.

7 May 2015

SLU study explores benefits of exercise and diet in managing Type 2 diabetes risk

In a paper recently published in Diabetes Care, Saint Louis University associate professor of nutrition and dietetics Edward Weiss, Ph.D, and colleagues found that, though people often think of the benefits from exercise, calorie restriction and weight loss as interchangeable, it appears that they may all offer distinct and cumulative benefits when it comes to managing Type 2 diabetes risk.

7 May 2015

Medilink UK Awards - The Winners 2015

The best of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2015 Medilink UK Awards.

6 May 2015

JDRF, Lilly partner to make life better for people with type 1 diabetes

JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Eli Lilly and Company, a global leader in diabetes care announced a two-year partnership that will provide $1.8 Million in support of JDRF's mission to improving the lives of people with T1D.

6 May 2015

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

6 May 2015

Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of gastric cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted an Orphan Drug Designation (ODD) for its lead product candidate, REOLYSIN, for the treatment of gastric cancers.

6 May 2015

BYU researchers shed new light on why people tend to snack at night

After gobbling the fourth Oreo in a row while bathed in refrigerator light, have you ever thought, "That wasn't enough," and then proceeded to search for something more? Researchers at BYU have shed new light on why you, your friends, neighbors and most everyone you know tend to snack at night: some areas of the brain don't get the same "food high" in the evening.

6 May 2015

Study offers new insights into construction of nuclear pores in nuclear envelope

In a recent study, a team of researchers led by Alwin Köhler at the Max F. Perutz Laboratories (MFPL) belonging to the University of Vienna and the Medical University of Vienna offer new insights into how nuclear pores are constructed in the nuclear envelope.

6 May 2015

Johns Hopkins researchers develop new strategies to treat depression in children, adolescents

A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.

6 May 2015

FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs

Beckman Coulter’s new, automated AQUIOS CL Flow Cytometer has received clearance from the U.

From Beckman Coulter Life Sciences - Flow Cytometry 5 May 2015

Mylan releases generic version of Seasonale Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets. Mylan's partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

5 May 2015

Food News and Research

WHO issues best practices for naming new human infectious diseases

Using mobile app to track intake of vitamin D and calcium

Bamboo could increase spread of hantavirus, warns WSU ecologist

UCI receives FDA consent to study stem cell-based treatment for retinitis pigmentosa in clinical trial

Cancer drugs get quick approvals despite little effect on patients, says York U researcher

Enlivant's Jerry Carson wins 2015 ALFA Hero Award

Unique real-time drug monitoring system

Elsevier launches new NFS Journal

Egalet announces business highlights, financial results for first quarter 2015

MSI completes patient recruitment for STRADA Phase 2 trial for treatment of major depressive disorder

SLU study explores benefits of exercise and diet in managing Type 2 diabetes risk

Medilink UK Awards - The Winners 2015

JDRF, Lilly partner to make life better for people with type 1 diabetes

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of gastric cancers

BYU researchers shed new light on why people tend to snack at night

Study offers new insights into construction of nuclear pores in nuclear envelope

Johns Hopkins researchers develop new strategies to treat depression in children, adolescents

FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs

Mylan releases generic version of Seasonale Tablets in the U.S.

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News